The impact on sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer treatment. [PDF]
Falla-Zuniga LF +8 more
europepmc +1 more source
Surgical education video: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer. [PDF]
Huizar GD +3 more
europepmc +1 more source
Sustained disease control in ovarian carcinosarcoma treated with postoperative hyperthermic intraperitoneal chemotherapy and targeted maintenance: a case report. [PDF]
Xu S +8 more
europepmc +1 more source
Advanced local jejunal carcinoma treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a case report and review of the literature. [PDF]
Armosh GA +6 more
europepmc +1 more source
Efficacy and safety of hyperthermic intraperitoneal chemotherapy in treatment of primary or recurrent ovarian cancer: systematic review and meta-analysis. [PDF]
Al Ameer AA +7 more
europepmc +1 more source
Prevalence and risk factors for postoperative incisional hernia after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta‑analysis and systematic review. [PDF]
Zeng Q, Yuan X, Wei X.
europepmc +1 more source
Thermally enhanced efficacy of chemotherapy potentiates cisplatin-based hyperthermic intraperitoneal chemotherapy in ovarian cancer. [PDF]
Yang F +9 more
europepmc +1 more source
Experiences of Fundamental Care Needs After Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy: A Qualitative Study. [PDF]
Bangsparr P, Jakobsson J.
europepmc +1 more source
Predicting PPOI secondary to laparoscopic radical resection of rectal cancer combined with lobaplatin hyperthermic intraperitoneal chemotherapy: a multi-center study. [PDF]
Zhang W +12 more
europepmc +1 more source
Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: <i>A single-institution case series</i>. [PDF]
Ravi PR +4 more
europepmc +1 more source

